Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis

Human Brain Mapping

Volumn 36, Issue 5, 2015, Pages 1796-1807

  Steenwijk, Martijn D ^a   Daams, Marita ^a   Pouwels, Petra J W ^a   J Balk, Lisanne ^a   Tewarie, Prejaas K ^a   Geurts, Jeroen J G ^a   Barkhof, Frederik ^a   Vrenken, Hugo ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diffusion tensor imaging; Gray matter atrophy; Magnetic resonance imaging; Multiple sclerosis; Volumetric magnetic resonance imaging

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; DIFFUSION TENSOR IMAGING; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FRACTIONAL ANISOTROPY; GLOBUS PALLIDUS; GRAY MATTER; GRAY MATTER ATROPHY; HIPPOCAMPUS; HUMAN; INSTITUTIONAL ETHICS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPORAL LOBE; WHITE MATTER; ANISOTROPY; ATROPHY; BOOK; BRAIN; COHORT ANALYSIS; IMAGE PROCESSING; MYELINATED NERVE; ORGAN SIZE; PATHOLOGY; STATISTICAL MODEL;

ANISOTROPY; ATLASES AS TOPIC; ATROPHY; BRAIN; COHORT STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; ORGAN SIZE; WHITE MATTER;

EID: 84927699194     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22738     Document Type: Article

References (49)

1. Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N (2009): Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis. J Neurol Sci 282:55-60.
2. Bendfeldt K, Kappos L, Radue EW, Borgwardt SJ (2009a): Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis. J Neurol Sci 285:268-9; author reply 269.
3. Bendfeldt K, Kuster P, Traud S, Egger H, Winklhofer S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Matthews PM, Nichols TE, Radue E-W, Borgwardt SJ (2009b): Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis-A longitudinal voxel-based morphometry study. Neuroimage 45:60-67.
4. Bendfeldt K, Klöppel S, Nichols TE, Smieskova R, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Radue E-W, Borgwardt SJ (2012): Multivariate pattern classification of gray matter pathology in multiple sclerosis. Neuroimage 60:400-408.
5. Bergsland N, Horakova D, Dwyer MG, Dolezal O, Seidl ZK, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R (2012): Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 33:1573-1578.
6. Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O (2009): Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: An in vivo study with TBSS and VBM. Hum Brain Mapp 30:2852-2861.
7. Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, McAuliffe MJM, Barachino L, Perini P, Fischl B, Battistin L, Gallo P (2007): Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 254:1212-1220.
8. Calabrese M, Filippi M, Rovaris M, Bernardi V, Atzori M, Mattisi I, Favaretto A, Grossi P, Barachino L, Rinaldi L, Romualdi C, Perini P, Gallo P (2009): Evidence for relative cortical sparing in benign multiple sclerosis: A longitudinal magnetic resonance imaging study. Mult Scler 15:36-41.
9. Calabrese M, Favaretto A, Poretto V, Romualdi C, Rinaldi F, Mattisi I, Morra A, Perini P, Gallo P (2013): Low degree of cortical pathology is associated with benign course of multiple sclerosis. Mult Scler 19:904-911.
10. Chard DT, Jackson JS, Miller DH, Wheeler-Kingshott CAM (2010): Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 32:223-228.
11. Charil A, Dagher A, Lerch JP, Zijdenbos AP, Worsley KJ, Evans AC (2007): Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability. Neuroimage 34:509-517.
12. Chen JT, Narayanan S, Collins DL, Smith SM, Matthews PM, Arnold DL (2004): Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage 23:1168-1175.
13. Daams M, Geurts JJG, Barkhof F (2013): Cortical imaging in multiple sclerosis. Curr Opin Neurol 26:345-352.
14. Dale AM, Fischl B, Sereno MI (1999): Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9:179-194.
15. De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, Federico A, Smith SM (2003): Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability. Neurology 60:1157-1162.
16. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006): An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968-980.
17. Fischl B, Sereno MI, Dale AM (1999): Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9:195-207.
18. Fisher E, Lee J-C, Nakamura K, Rudick R a (2008): Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol 64:255-265.
19. Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel K a, Thompson AJ, Miller DH (2008): Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 64:247-254.
20. Furby J, Hayton T, Altmann D, Brenner R, Chataway J, Smith KJ, Miller DH, Kapoor R (2009): Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis. Mult Scler 15:687-694.
21. Geurts JJG, Barkhof F (2008): Grey matter pathology in multiple sclerosis. Lancet Neurol 7:841-851.
22. Henry RG, Shieh M, Okuda DT, Evangelista A, Gorno-Tempini ML, Pelletier D (2008): Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 79:1236-1244.
23. Henry RG, Shieh M, Amirbekian B, Chung S, Okuda DT, Pelletier D (2009): Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. J Neurol Sci 282:61-66.
24. Hulst HE, Geurts JJG (2011): Gray matter imaging in multiple sclerosis: What have we learned? BMC Neurol 11:153.
25. Jehna M, Langkammer C, Khalil M, Fuchs S, Reishofer G, Fazekas F, Ebner F, Enzinger C (2013): An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in Multiple Sclerosis. Brain Connect:1-47.
26. Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Radü E-W, Bauer L, Dahms S, Lanius V, Pohl C, Sandbrink R (2007): Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: A 3-year follow-up analysis of the BENEFIT study. Lancet 370:389-397.
27. Kurtzke JF (1983): Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33:1444-1452.
28. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H (2005): Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705-2712.
29. Mikol DD, Barkhof F, Chang P, Coyle PK, Jeffery DR, Schwid SR, Stubinski B, Uitdehaag BMJ (2008): Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): A multicentre, randomised, parallel, open-label trial. Lancet Neurol 7:903-914.
30. Mistry N, Abdel-Fahim R, Mougin O, Tench C, Gowland P, Evangelou N (2014): Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter. Mult Scler 20:227-233.
31. Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R (2013): White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: Support from structural MRI. Mult Scler.
32. Narayana P a., Govindarajan K a., Goel P, Datta S, Lincoln J a., Cofield SS, Cutter GR, Lublin FD, Wolinsky JS (2013): Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study. NeuroImage Clin 2:120-131.
33. Pagani E, Rocca M a, Gallo A, Rovaris M, Martinelli V, Comi G, Filippi M (2005): Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol 26:341-346.
34. Patenaude B, Smith SM, Kennedy DN, Jenkinson M (2011): A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907-922.
35. Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, Wu K, Waldman A, Malik O, Matthews PM, Reynolds R, Nicholas R, Piccini P (2012): Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology 79:523-530.
36. Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW (2006): A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899-910.
37. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011): Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292-302.
38. Popescu V, Klaver R, Voorn P, Galis-de Graaf Y, Knol D, Twisk J, Versteeg A, Schenk G, Van der Valk P, Barkhof F, De Vries H, Vrenken H, Geurts J. What drives MRI-measured cortical atrophy in multiple sclerosis? Mult Scler. 2015 Jan 12. pii: 1352458514562440. [Epub ahead of print]
39. Ramasamy DP, Benedict RHB, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R (2009): Extent of cerebellum, subcortical and cortical atrophy in patients with MS: A case-control study. J Neurol Sci 282:47-54.
40. Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, Kappos L, Pelletier D, Hauser SL, Matthews PM, Barkhof F, Geurts JJG (2011): Grey matter volume in a large cohort of MS patients: Relation to MRI parameters and disability. Mult Scler 17:1098-1106.
41. Sailer M, Fischl B, Salat D, Tempelmann C, Schönfeld MA, Busa E, Bodammer N, Heinze H-J, Dale A (2003): Focal thinning of the cerebral cortex in multiple sclerosis. Brain 126:1734-1744.
42. Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, Miller DH, Thompson AJ (2004): Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage 22:353-359.
43. Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L, Polman CH, Geurts JJG, Barkhof F (2012): Subcortical atrophy and cognition: Sex effects in multiple sclerosis. Neurology 79:1754-1761.
44. Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez De Mendizábal N, Toledo JB, Villoslada P (2009): Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: Evidence from voxel-based analysis of T1 lesions in the visual pathway. Arch Neurol 66:173-179.
45. Steenwijk MD, Pouwels PJW, Daams M, Dalen JW van, Caan MWA, Richard E, Barkhof F, Vrenken H (2013): Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs). NeuroImage Clin 3:462-469.
46. Steenwijk MD, Daams M, Pouwels PJW, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BMJ, Geurts JJG, Barkhof F, Vrenken H (2014): What explains gray matter atrophy in long-standing multiple sclerosis? Radiology: 132708.
47. Tedeschi G, Lavorgna L, Russo P, (2005): Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology 65:280-285.
48. Vrenken H, Pouwels PJW, Geurts JJG, Knol DL, Polman CH, Barkhof F, Castelijns JA (2006): Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: Cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 23:628-636.
49. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM (2006): Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67:960-967.